FATE THERAPEUTICS INC Annual Return On Equity in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Fate Therapeutics Inc quarterly/annual Return On Equity history and growth rate from 2014 to 2023.
  • Fate Therapeutics Inc Return On Equity for the quarter ending September 30, 2024 was -45.9 %, a 19.4% decline year-over-year.
  • Fate Therapeutics Inc annual Return On Equity for 2023 was -38.2 %, a 25% increase from 2022.
  • Fate Therapeutics Inc annual Return On Equity for 2022 was -50.9 %, a 76.9% decline from 2021.
  • Fate Therapeutics Inc annual Return On Equity for 2021 was -28.8 %, a 37.7% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -38.2 +12.7 +25% Jan 1, 2023 Dec 31, 2023
2022 -50.9 -22.1 -76.9% Jan 1, 2022 Dec 31, 2022
2021 -28.8 +17.4 +37.7% Jan 1, 2021 Dec 31, 2021
2020 -46.2 +3.77 +7.55% Jan 1, 2020 Dec 31, 2020
2019 -49.9 +9.1 +15.4% Jan 1, 2019 Dec 31, 2019
2018 -59 +12 +16.8% Jan 1, 2018 Dec 31, 2018
2017 -71 +16.8 +19.2% Jan 1, 2017 Dec 31, 2017
2016 -87.8 -10.6 -13.8% Jan 1, 2016 Dec 31, 2016
2015 -77.2 -6.66 -9.44% Jan 1, 2015 Dec 31, 2015
2014 -70.6 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.